Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells

被引：42

作者：

Jia, Bin ^{[1
,2
,3
]}

Choy, Edwin ^{[1
,2
]}

Cote, Gregory ^{[1
,2
]}

Harmon, David ^{[1
,2
]}

Ye, Shunan ^{[1
,2
]}

Kan, Quancheng ^{[3
]}

Mankin, Henry ^{[1
,2
]}

Hornicek, Francis ^{[1
,2
]}

Duan, Zhenfeng ^{[1
,2
]}

机构：

[1] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Pharmacol, Zhengzhou 450052, Henan, Peoples R China

来源：

CANCER LETTERS | 2014年 / 342卷 / 01期

基金：

美国国家卫生研究院;

关键词：

Kinase; Liposarcoma; CDK11; Tissue microarray; Immunohistochemistry; ADVANCED SOLID TUMORS; SOFT-TISSUE SARCOMA; I CLINICAL-TRIAL; PHASE-I; DEDIFFERENTIATED LIPOSARCOMA; INHIBITOR FLAVOPIRIDOL; C-JUN; OSTEOSARCOMA; EXPRESSION; COMPLEXES;

D O I：

10.1016/j.canlet.2013.08.040

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Liposarcoma is the second most common soft tissue sarcoma in adults, but treatment options have been quite limited thus far. In this study, we investigated the functional and therapeutic relevance of cyclin-dependent kinase 11 (CDK11) as a putative target in liposarcoma. CDK11 knockdown by synthetic siRNA or lentiviral shRNA decreased cell proliferation, and induced apoptosis in liposarcoma cells. Moreover, CDK11 knockdown enhances the cytotoxic effect of doxorubicin to inhibit cell growth in liposarcoma cells. These findings suggest that CDK11 is critical for the growth and proliferation of liposarcoma cells. CDK11 may be a promising therapeutic target for the treatment of liposarcoma patients. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

引用

下载

页码：104 / 112

页数：9

共 50 条

[31] Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors
Fernanda Hayashida Yoshimoto
Cecilia Félix Penido Mendes de Sousa
Gustavo Nader Marta
Samir Abdallah Hanna
Current Oncology Reports, 2023, 25 : 1153 - 1159
[32] Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors
Yoshimoto, Fernanda Hayashida
de Sousa, Cecilia Felix Penido Mendes
Marta, Gustavo Nader
Hanna, Samir Abdallah
CURRENT ONCOLOGY REPORTS, 2023, 25 (10) : 1153 - 1159
[33] The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis
Hakem, A
Sasaki, T
Kozieradzki, I
Penninger, JM
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06): : 957 - 967
[34] Impact of Cyclin-Dependent Kinase CDK4 Inhibition on Eryptosis
Lang, Elisabeth
Zelenak, Christine
Eberhard, Matthias
Bissinger, Rosi
Rotte, Anand
Ghashghaeinia, Mehrdad
Lupescu, Adrian
Lang, Florian
Qadri, Syed M.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 37 (03) : 1178 - 1186
[35] Regulation of telomere elongation by the cyclin-dependent kinase CDK1
Frank, Christopher J.
Hyde, Molly
Greider, Carol W.
MOLECULAR CELL, 2006, 24 (03) : 423 - 432
[36] Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells
Matsumoto, Y
Hayashi, K
Nishida, E
CURRENT BIOLOGY, 1999, 9 (08) : 429 - 432
[37] BOTH P16 AND P21 FAMILIES OF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS BLOCK THE PHOSPHORYLATION OF CYCLIN-DEPENDENT KINASES BY THE CDK-ACTIVATING KINASE
APRELIKOVA, O
XIONG, Y
LIU, ET
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) : 18195 - 18197
[38] Mouse cyclin-dependent kinase (Cdk) 5 is a functional homologue of a yeast Cdk, Pho85 kinase
Nishizawa, M
Kanaya, Y
Toh-e, A
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) : 33859 - 33862
[39] Rux is a cyclin-dependent kinase inhibitory (CKI) specific for mitotic cyclin-Cdk complexes
Foley, E
O'Farrell, PH
Sprenger, F
CURRENT BIOLOGY, 1999, 9 (23) : 1392 - 1402
[40] Cyclin-dependent kinase 11p110 activity in the absence of CK2
Sachs, NA
Vaillancourt, RR
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2003, 1624 (1-3): : 98 - 108

← 1 2 3 4 5 →